Wuhan Keqian Biology Co Ltd (688526) - Total Liabilities

Latest as of September 2025: CN¥580.21 Million CNY ≈ $84.90 Million USD

Based on the latest financial reports, Wuhan Keqian Biology Co Ltd (688526) has total liabilities worth CN¥580.21 Million CNY (≈ $84.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Wuhan Keqian Biology Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Wuhan Keqian Biology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Wuhan Keqian Biology Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Wuhan Keqian Biology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wuhan Keqian Biology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Haohai Biological Tech Co SHG:688366	China	CN¥1.23 Billion
Rongan Property Co Ltd SHE:000517	China	CN¥6.58 Billion
Beijing WKW Automotive Parts Co Ltd SHE:002662	China	CN¥1.47 Billion
Lg Electronics Pref KO:066575	Korea	₩40.25 Trillion
Jiangyin Haida Rubber and Plastic Co Ltd Class A SHE:300320	China	CN¥1.22 Billion
Farmers National Banc Corp NASDAQ:FMNB	USA	$6.41 Billion
Guangdong Mingzhu Group Co Ltd SHG:600382	China	CN¥580.64 Million
Hiconics Drive Tech Co SHE:300048	China	CN¥3.06 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Wuhan Keqian Biology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Wuhan Keqian Biology Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Keqian Biology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Keqian Biology Co Ltd (2016–2024)

The table below shows the annual total liabilities of Wuhan Keqian Biology Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥552.80 Million ≈ $80.89 Million	-33.68%
2023-12-31	CN¥833.59 Million ≈ $121.98 Million	-6.51%
2022-12-31	CN¥891.63 Million ≈ $130.47 Million	+56.04%
2021-12-31	CN¥571.41 Million ≈ $83.62 Million	+42.00%
2020-12-31	CN¥402.40 Million ≈ $58.88 Million	+59.38%
2019-12-31	CN¥252.48 Million ≈ $36.95 Million	-28.58%
2018-12-31	CN¥353.51 Million ≈ $51.73 Million	+36.57%
2017-12-31	CN¥258.86 Million ≈ $37.88 Million	+44.61%
2016-12-31	CN¥179.01 Million ≈ $26.19 Million	--

About Wuhan Keqian Biology Co Ltd

SHG:688526 China Biotechnology

Market Cap

$838.29 Million

CN¥5.73 Billion CNY

Market Cap Rank

#9856 Global

#2625 in China

Share Price

CN¥12.29

Change (1 day)

+0.08%

52-Week Range

CN¥12.18 - CN¥19.33

All Time High

CN¥47.40